Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for bronchial carcinoma].

B Milleron1, D Moro-Sibilot,

  • 1Unité fonctionnelle de pneumologie à orientation oncologique, Hôpital Tenon, Paris.

Journal De Radiologie
|January 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovative therapeutic cancer vaccine PDC<sup>∗</sup>lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer.

ESMO open·2025
Same author

Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study.

ESMO open·2022
Same author

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.

ESMO open·2021
Same author

[Implication of bronchopulmonary cancer patients in thoracic oncology].

Revue des maladies respiratoires·2021
Same author

Revue des maladies respiratoires actualites·2021
Same author

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same journal

[Not Available].

Journal de radiologie·2014
Same journal

[Not Available].

Journal de radiologie·2014
Same journal

[Not Available].

Journal de radiologie·2014
Same journal

[Not Available].

Journal de radiologie·2014
Same journal

[Not Available].

Journal de radiologie·2014
Same journal

[Not Available].

Journal de radiologie·2014
See all related articles

Screening for bronchial carcinoma (lung cancer) using low-dose CT scans shows promise for early detection. However, randomized trials are needed to prove if lung cancer screening reduces mortality rates.

Area of Science:

  • Oncology
  • Radiology
  • Public Health

Background:

  • Bronchial carcinoma remains a leading cause of cancer mortality.
  • Unlike breast and colon cancers, the mortality reduction benefits of lung cancer screening are not yet established.
  • Advancements in low-dose spiral CT scanning have renewed interest in lung cancer screening.

Purpose of the Study:

  • To evaluate the potential of low-dose spiral CT scanning for early detection of bronchial carcinoma.
  • To assess preliminary data suggesting improved survival rates for lung cancers detected through screening.
  • To determine if screening for bronchial carcinoma can definitively reduce patient mortality.

Main Methods:

  • Review of preliminary studies on low-dose spiral CT scanning for lung cancer detection.

Related Experiment Videos

  • Analysis of data suggesting improved survival in screened patients.
  • Emphasis on the necessity of randomized controlled trials (RCTs) to confirm screening efficacy.

    • Main Results:

    • Preliminary studies indicate that CT scanning detects 2/3 of bronchial carcinomas at an early stage.
    • Some data suggest a potential improvement in survival for tumors discovered via screening.
    • Definitive proof of mortality reduction through screening is still lacking.

    Conclusions:

    • Current consensus does not support mass screening for bronchial carcinoma using CT scans.
    • High-risk individuals are encouraged to participate in RCTs to validate the effectiveness of lung cancer screening.
    • Further research through RCTs is crucial to confirm or refute the value of CT screening in reducing lung cancer mortality.